NONINVASIVE AND CURATIVE RADIATION THERAPY FOR SEBACEOUS CARCINOMA OF THE EYELID

被引:34
作者
Hata, Masaharu [1 ]
Koike, Izumi
Omura, Motoko
Maegawa, Jiro [2 ]
Ogino, Ichiro [3 ]
Inoue, Tomio
机构
[1] Yokohama City Univ, Grad Sch Med, Dept Radiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Yokohama, Kanagawa 2360004, Japan
[3] Yokohama City Univ, Med Ctr, Dept Radiat Oncol, Yokohama, Kanagawa 2360004, Japan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 82卷 / 02期
关键词
Eyelid; Organ preservation; Radiation therapy; Sebaceous carcinoma; MEIBOMIAN GLAND CARCINOMA; ORBITAL LYMPHOMA; PAGETOID SPREAD; CELL-CARCINOMA; ONCOLOGY-GROUP; OCULAR ADNEXA; MITOMYCIN-C; MANAGEMENT; RADIOTHERAPY; ADENOCARCINOMA;
D O I
10.1016/j.ijrobp.2010.12.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Sebaceous carcinoma of the eyelid is a rare malignancy. Surgical excision remains the standard and most reliable curative treatment. However, surgery is sometimes not possible because many patients are elderly, and it frequently causes functional and cosmetic impairment of the eyelid. We therefore carried out a study to determine: the role of radiation therapy in relation to sebaceous carcinoma of the eyelid. Methods and Materials: Thirteen patients with sebaceous carcinoma of the eyelid underwent radiation therapy with curative intent. There were 6 men and 7 women, and their ages at irradiation ranged from 60 to 85 years (me.. dian, 78 years). Only 1 patient had cervical lymph node metastasis, and none of the patients had distant metastasis. A total dose of 50 to 66.6 Gy (median, 60 Gy) was delivered to tumor sites in 22 to 37 fractions. Results: All irradiated tumors were controlled at a median follow-up period of 55 months. Only 1 patient had re.. currence of cervical lymph node metastasis outside the radiation field, at 22 months after irradiation. The 5-year local progression free and disease-free rates were 100% and 89%, respectively. The overall and disease-free sur. vival rates at 5 years were 100% and 89%, respectively. Although acute and transient therapy-related reactions of Grade 2 or less were observed, there were no severe toxicities of Grade 3 or greater. Conclusions: Radiation therapy is a safe and effective treatment for patients with sebaceous carcinoma of the eye.. lid. It appears to contribute to prolonged survival as a result of good tumor control, and it also facilitates functional and cosmetic preservation of the eyelid. (C) 2012 Elsevier Inc.
引用
收藏
页码:605 / 611
页数:7
相关论文
共 39 条
[1]   Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy [J].
Berenbom, A. ;
Davila, R. M. ;
Lin, H-S ;
Harbour, J. W. .
EYE, 2007, 21 (09) :1198-1201
[2]   Radiotherapy in the management of orbital lymphoma [J].
Bolek, TW ;
Moyses, HM ;
Marcus, RB ;
Gorden, L ;
Maiese, RL ;
Almasri, NM ;
Mendenhall, NP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (01) :31-36
[3]   Sebaceous carcinoma of the eyelid: A review of 14 cases [J].
Callahan, EF ;
Appert, DL ;
Roenigk, RK ;
Bartley, GB .
DERMATOLOGIC SURGERY, 2004, 30 (08) :1164-1168
[4]   TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) [J].
COX, JD ;
STETZ, J ;
PAJAK, TF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05) :1341-1346
[5]   Management of eyelid sebaceous carcinomas [J].
Dogru, M ;
Matsuo, H ;
Inoue, M ;
Okubo, K ;
Yamamoto, M .
OPHTHALMOLOGICA, 1997, 211 (01) :40-43
[6]   SEBACEOUS GLAND CARCINOMA - REVIEW OF 40 CASES [J].
DOXANAS, MT ;
GREEN, WR .
ARCHIVES OF OPHTHALMOLOGY, 1984, 102 (02) :245-249
[7]   Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy [J].
Ejima, Y ;
Sasaki, R ;
Okamoto, Y ;
Maruta, T ;
Azumi, A ;
Hayashi, Y ;
Demizu, Y ;
Ota, Y ;
Soejima, T ;
Sugimura, K .
RADIOTHERAPY AND ONCOLOGY, 2006, 78 (01) :6-9
[8]  
EPSTEIN GA, 1983, OPHTHALMIC SURG LAS, V14, P935
[9]  
HARVEY JT, 1982, OPHTHALMIC SURG LAS, V13, P56
[10]   PRIMARY RADIATION-THERAPY FOR MEIBOMIAN GLAND CARCINOMA [J].
HENDLEY, RL ;
RIESER, JC ;
CAVANAGH, HD ;
BODNER, BI ;
WARING, GO .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1979, 87 (02) :206-209